3rd Measuring Patient Engagement Summit
30 30 people viewed this event.
Patient engagement is no longer optional – it’s a strategic imperative.
Regulators expect defensible evidence, executives demand clear ROI, and tighter funding and portfolio scrutiny mean every engagement activity must demonstrate real value. Yet across the industry, organizations still struggle to prove the impact of their efforts.
Time: 8:00 am to 4:20 pm
Prices: USD 2699.00 – USD 5397.00
Speakers: Dawn Aubel, Senior Director – Patient Centered Development, Cardiovascular, Renal and Metabolism, AstraZeneca and more
Venue details: The Colonnade, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
Event Organizer: Hanson Wade